Perfetti Riccardo's Form 4 filing
Applied Therapeutics, Inc. (APLT) · filed Mar 23, 2022
- Accession no.
- 0001209191-22-020837
- Filed
- Mar 23, 2022
- Trade date
- Mar 21-23, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $125.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Perfetti RiccardoCIK 0001775410 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 21, 2022 | Common Stock | PPurchaseAcquired | +12,548 | $1.85F2 | +$23,213.8 | 108,948 | Direct | |
| Mar 22, 2022 | Common Stock | PPurchaseAcquired | +21,961 | $1.98F3 | +$43,482.78 | 130,909 | Direct | |
| Mar 23, 2022 | Common Stock | PPurchaseAcquired | +30,000 | $1.97F4 | +$59,100 | 160,909 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Weighted average price. These shares were purchased by Dr. Perfetti in multiple transactions at prices ranging from $1.8100 to $1.9200 inclusive. The reporting undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Referenced by the price of 1 transaction in Table I.
- F3
Weighted average price. These shares were purchased by Dr. Perfetti in multiple transactions at prices ranging from $1.9000 to $2.0900 inclusive. The reporting undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Referenced by the price of 1 transaction in Table I.
- F4
Weighted average price. These shares were purchased by Dr. Perfetti in multiple transactions at prices ranging from $1.8600 to $2.1000 inclusive. The reporting undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Referenced by the price of 1 transaction in Table I.